Publications by authors named "Nicholas J Golda"
Article Synopsis
- A study was conducted to analyze how often dermatologic surgeons face challenges in identifying the locations of skin cancer tumors before surgery.
- Out of over 17,000 cases, only 0.60% involved uncertain sites, with these cases more common in older, male patients who had biopsies done over a month prior.
- Surgeons commonly used various methods to confirm tumor locations, achieving success in identifying 82% of these uncertain sites, while some surgeries were delayed, especially for non-facial tumors.
Background: Limited data exists for bupivacaine injection after Mohs micrographic surgery (MMS).
Objective: Evaluate how bupivacaine affects postoperative pain and narcotic use.
Materials And Methods: In this multicenter, single-blinded, prospective randomized controlled trial, patients received bupivacaine or saline (placebo) immediately after MMS with flap reconstructions identified by American Academy of Dermatology expert consensus as high-risk for pain and narcotic use.
Importance: It has been suggested that Mohs surgery for skin cancer among individuals with limited life expectancy may be associated with needless risk and discomfort, along with increased health care costs.
Objective: To investigate patient- and tumor-specific indications considered by clinicians for treatment of nonmelanoma skin cancer in older individuals.
Design, Setting, And Participants: This multicenter, prospective cohort study was conducted using data from US private practice and academic centers.
Background: Dermatologic surgery is associated with low postoperative infection rates, averaging from approximately 1% to 4.25%. Often, postoperative infections are treated empirically based on clinical diagnosis of infection, given it can take 48 to 72 hours for a wound culture to identify a pathogen.
View Article and Find Full Text PDFBipedicled conchal bowl composite sling flap for reconstruction of the upper third of the ear.
J Plast Reconstr Aesthet Surg
February 2018